T-cell-mediated hypersensitivity to lumacaftor and ivacaftor in cystic fibrosis. (2022)

First Author: Semic-Jusufagic A
Attributed to:  Centre for Drug Safety Science (CDSS) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1111/pai.13815

PubMed Identifier: 35754124

Publication URI: http://europepmc.org/abstract/MED/35754124

Type: Journal Article/Review

Volume: 33

Parent Publication: Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology

Issue: 6

ISSN: 0905-6157